Biologically Active Peptides Released in Fermented Milk: Role and Functions

Handbook of Fermented Functional Foods

Volumn , Issue , 2003, Pages 177-202

  Matar, Chantal ^a   Leblanc, Jean Guy ^a   Martin, Luc ^a   Perdigón, Gabriela ^b  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85145125271     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203009727-12     Document Type: Chapter

References (132)

1. Marteau, P., Seksik, P., and Jian, R., Probiotics and intestinal health effects: a clinical perspective, Br. J. Nutr., 88, S51–S57, 2002.
2. Fuller, R., Ed., Probiotics 3: Immunomodulation by the Gut Flora and Probiotics, Kluwer Academic Press, Dordrecht, The Netherlands, 2000.
3. Yoshikawa, M., Fujita, H., Matoba, N., Takenaka, Y., Yamamoto, T., Yamauchi, R., Tsuruki, H., and Takahata, K., Bioactive peptides derived from food proteins preventing lifestyle-related diseases, Biofactors, 12, 143–146, 2000.
4. Yamauchi, F. and Suetsuna, K., Immunological effects of dietary peptide derived from soybean protein, J. Nutr. Biochem., 4, 450–457, 1993.
5. Takahashi, M., Moriguchi, S., Ikeno, M., Kono, S., Ohata, K., Usui, H., Kurahashi, K., Sasaki, R., and Yoshikawa, M., Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albumin, Peptides, 17, 5–12, 1996.
6. Meisel, H. and Bockelmann, W., Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties, Antonie Van Leeuwenhoek, 76, 207–215, 1999.
7. Clare, D.A. and Swaisgood, H.E., Bioactive milk peptides: a prospectus, J. Dairy Sci., 83, 1187–1195, 2000.
8. Juillard, V., Guillot, A., Le Bars, D., and Gripon, J.C., Specificity of milk peptide utilization by Lactococcus lactis, Appl. Environ. Microbiol., 64, 1230–1236, 1998.
9. Kunji, E.R., Mierau, I., Hagting, A., Poolman, B., and Konings, W.N., The proteolytic systems of lactic acid bacteria, Antonie Van Leeuwenhoek, 70, 187–221, 1996.
10. Kunji, E.R., Fang, G., Jeronimus-Stratingh, C.M., Bruins, A.P., Poolman, B., and Konings, W.N., Reconstruction of the proteolytic pathway for use of beta-casein by Lactococcus lactis, Mol. Microbiol., 27, 1107–1118, 1998.
11. Mierau, I., Kunji, E.R., Venema, G., and Kok, J., Casein and peptide degradation in lactic acid bacteria. Biotechnol. Gen. Engin. Rev., 14, 279–301, 1997.
12. Law, J. and Handrikmann, A., Proteolytic enzymes of lactic acid bacteria, Int. Dairy J., 7, 1–15, 1997.
13. Visser, S., Exterkate, F.A., Slangen, C.J., and de Veer, G.J.C.M., Comparative study of action of cell wall proteinases from various strains of Streptococcus cremoris on bovine aS1-, ß-, and K-casein, Appl. Environ. Microbiol., 52, 1162–1166, 1986.
14. Kunji, E.R., Smid, E.J., Plapp, R., Poolman, B., and Konings, W.N., Di-tripeptides and oligopeptides are taken up via distinct transport mechanisms in Lactococcus lactis, J. Bacteriol., 175, 2052–2059, 1993.
15. Kok, J., van der Vossen, J.M.B.M., and Venema, G., Construction of plasmid cloning vectors for lactic streptococci which are replicate in Bacillus subtilis and Escherichia coli, Appl. Environ. Microbiol., 48, 726–731, 1984.
16. Haandrikman, A.J., Kok, J., Laan, H., Soemitro, S., Ledeboer, A.M., Konings, W.N., and Venema, G., Identification of a gene required for the maturation of an extracellular serine proteinase, J. Bacteriol., 171, 2789–2795, 1989.
17. Vos, P., Simons, G., Siezen, R.J., and de Vos, W.M., Primary structure and organisation of the genes for procaryotic, cell envelope–located serine proteinase, J. Biol. Chem., 264, 13579–13585, 1989.
18. von Heijne, G., Membrane proteins. The amino acid composition of membrane penetrating segments, Eur. J. Biochem., 120, 275–278, 1981.
19. Martín-Hernández, M.C., Alting, A.C., and Exterkate, F.A., Purification and characterization of the mature, membrane-associated cell-envelope proteinase of Lactobacillus helveticus L89, Appl. Microbiol. Biotechnol., 40, 828–834, 1994.
20. Foucaud, C. and Juillard, V., Accumulation of casein-derived peptides during growth of proteinase-positive strains of Lactococcus lactis in milk: their contribution to subsequent bacterial growth is impaired by their internal transport, J. Dairy Res., 67, 233–240, 2000.
21. Tan, P.S.T., Pos, K.M., and Konings, W., Purification and characterization of an endopeptidase from Lactococcus lactis subsp. cremoris Wg2, Appl. Environ. Microbiol., 57, 3593–3599, 1991.
22. Booth, M., Ní Fhaolain, I., Jennings, P.V., and O’Cuinn, G., Purification and characterization of a post-proline dipeptidyl aminopeptidase from Streptococcus cremoris AM2, J. Dairy Res., 57, 89-99, 1990.
23. Baankreis, R. and Exterkate, F.A., Characterization of a peptidase from Lactococcus lactis ssp. cremoris HP that hydrolyses di- and tripeptides containing proline or hydrophobic residues at the aminoterminal amino acid, System. Appl. Microbiol., 14, 317-323, 1991.
24. Atlan, D., Laloi, P., and Portalier, R., X-prolyldipeptidyl aminopeptidase of Lactobacillus delbrueckii subsp. bulgaricus: characterization of the enzyme and isolation of deficient mutants, Appl. Environ. Microbiol., 56, 2174-2179, 1990.
25. Tynkkynen, S., Buist, G., Kunji, E., Kok, J., Poolman, B., Venema, G., and Haandrikman, A., Genetic and biochemical characterization of the oligopeptide transport system of Lactococcus lactis: demonstration of the essential role of oligopeptide transport in the utilization of casein, J. Bacteriol., 175, 7523-7532, 1993.
26. Chabance, B., Marteau, P., Rambaud, J.C., Migliore-Samour, D., Boynard, M., Per-rotin, P., Guillet, R., Jolles, P., and Fiat, A.M., Casein peptide release and passage to the blood in humans during digestion of milk or yogurt, Biochimie, 80, 155-165, 1998.
27. Matar, C. and Goulet, J., ß-Casomorphin 4 from milk fermented by a mutant of Lactobacillus helveticus, Int. Dairy J., 6, 383-397, 1996.
28. Yamamoto, N. and Takano, T., Antihypertensive peptides derived from milk proteins, Nahrung, 43, 159–164, 1999.
29. Matar, C., Nadathur, S.S., Bakalinsky, A.T., and Goulet, J., Antimutagenic effects of milk fermented by Lactobacillus helveticus L89 and a protease-deficient derivative, J. Dairy Sci., 80, 1965–1970, 1997.
30. Maeno, M., Yamamoto, N., and Takano, T., Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus hel-veticus CP790, J. Dairy Sci., 79, 1316–1321, 1996.
31. Yamamoto, N., Akino, A., and Takano, T., Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790, J. Dairy Sci., 77, 917–922, 1994.
32. Belem, M.A.F., Gibbs, B.F., and Lee, B.H., Proposing sequence for peptides derived from whey fermentation with potential bioactive sites, J. Dairy Sci., 82, 486–493, 1999.
33. Rokka, T., Syvaoja, E.L., Tuominen, J., and Korhonen, H., Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT milk, Milch-wissenschaft, 52, 675–678, 1997.
34. Smacchi, E. and Gobbetti, M., Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes, Food Microbiol., 17, 129–141, 2000.
35. Roudot-Algaron, F., LeBars, D., Kerhoas, L., Einhorn, J., and Gripon, J.C., Phospho-peptides from Comté cheese: nature and origin, J. Food Sci., 59, 544–547, 1994.
36. Pellegrino, L., Battelli, G., Resmini, P., Ferranti, P., Barone, F., and Addeo, F., Alkaline phosphatase inactivation during Grana Padano cheese-making and related effects on cheese characterization and ripening, Lait, 77, 217–228, 1997.
37. Smacchi, E. and Gobbetti, M., Peptides from Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria, Pseudomonas fluorescens ATCC 948 and to the angiotensin-I converting enzyme, Enzyme Microb. Technol., 22, 687–694, 1998.
38. Meisel, H., Goepfert, A., and Günther, S., ACE-inhibitory activities in milk products, Milchwissenschaft, 52, 307–311, 1997.
39. Addeo, F., Chianese, L., Salzano, A., Sacchi, R., Cappuccio, U., Ferranti, P., and Malorni, A., Characterization of the 12% tricholoroacetic acid-insoluble oligopeptides of Parmigiano–Reggiano cheese, J. Dairy Res., 59, 401–411, 1992.
40. Gobbetti, M., Stepaniak, L., Fox, P.F., Sorhaug, T., and Tobiassen, R., Inhibition of endo- and amino-peptidase activities in cytoplasmic fractions of Lactococcus, Lactobacillus and Propionibacterium by peptides from different cheeses, Milchwissen-schaft, 50, 565–570, 1995.
41. Stepaniak, L., Fox, P.F., Sørhaug, T., and Grabska, J., Effect of peptides from the sequence 58–72 of ß-casein on the activity of endopeptidase, aminopeptidase and X-prolyl-dipeptidyl aminopeptidase from Lactoccocus, J. Agric. Food Chem., 43, 849–853, 1995.
42. Perdigon, G., Alvarez, S., Rachid, M., Aguero, G., and Gobbato, N., Immune system stimulation by probiotics, J. Dairy Sci., 78, 1597–1606, 1995.
43. Perdigon, G., Vintini, E., Alvarez, S., Medina, M., and Medici, M., Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria, J. Dairy Sci., 82, 1108–1114, 1999.
44. Perdigon, G. and Holgado, A., Mechanisms involved in the immunostimulation by lactic acid bacteria, in Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics, Fuller, R., Ed., Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000, pp. 213–229.
45. Perdigon, G., Fuller, R., and Raya, R., Lactic acid bacteria and their effect on the immune system, Curr. Issues Intest. Microbiol., 2, 27–42, 2001.
46. Schiffrin, E.J., Brassart, D., Servin, A.L., Rochat, F., and Donnet-Hughes, A., Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection, Am. J. Clin. Nutr., 66, 515S–520S, 1997.
47. Ayebo, A.D., Shahani, K.M., Dam, R., and Friend, B.A., Ion exchange separation of the antitumor component(s) of yogurt dialyzate, J. Dairy Sci., 65, 2388–2390, 1982.
48. Biffi, A., Coradini, D., Larsen, R., Riva, L., and Di Fronzo, G., Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line, Nutr. Cancer, 28, 93–99, 1997.
49. Perdigon, G., de Marcia, M.E.N., Alvarez, S., Medici, M., Oliver, G., and de Ruiz Holgado, A.P., Effect of a mixture of Lactobacillus casei and Lactobacillus acidophilus administered orally on the immune system in mice, J. Food Prot., 49, 986–989, 1986.
50. de Simone, C., Slavadori, B.B., Negri, R., Ferrazzi, M., Bladinelli, L., and Vesely, R., The adjuvant effect of yogurt on production of gamma-interferon by con a-stimulated human peripheral blood lymphocytes, Nutr. Rep. Int., 33, 419–433, 1986.
51. Ng, K.-Y. and Griffiths, M.W., Enhancement of macrophage cytokine release by cell-free fractions of fermented milk, Milchwissenschaft, 57, 66–70, 2002.
52. Sutas, Y., Soppi, E., and Korhonen, H., Suppression of lymphocyte proliferation in vitro by bovine caseins hydrolyzed with Lactobacillus casei GG-derived enzymes, J. Allergy Clin. Immunol., 98, 216–224, 1996.
53. Laffineur, E., Genetet, N., and Leonil, J., Immunomodulatory activity of beta-casein permeate medium fermented by lactic acid bacteria, J. Dairy Sci., 79, 2112–2120, 1996.
54. Otani, H., Monnai, M., Kawasaki, Y., Kawakami, H., and Tanimoto, M., Inhibition of mitogen-induced proliferation responses of lymphocytes by bovine K-caseinogly-copeptides having different carbohydrate chains, J. Dairy Res., 62, 349–357, 1995.
55. Kayser, H. and Meisel, H., Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins, FEBS Lett., 383, 18–20, 1996.
56. Gill, H.S., Doull, F., Rutherford, K.J., and Cross, M.L., Immunoregulatory peptides in bovine milk, Br. J. Nutr., 84, S111–S117, 2000.
57. Sutas, Y., Hurne, M., and Isolauri, E., Down-regulation of CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG–derived enzymes, Scand. J. Immunol., 43, 687–689, 1996.
58. Parker, F., Migliore-Samour, D., and Floc’h, F., Immunostimulating hexapeptide from human casein, amino acid sequence, synthesis and biological properties, Eur. J. Bio-chem., 145, 677–682, 1984.
59. Otani, H. and Hata, I., Inhibition of proliferation responses of mouse spleen lymphocytes and rabbit Peyer’s patch cells by bovine milk caseins and their digests, J. Dairy Res., 62, 339-348, 1995.
60. Jolles, P., Fiat, A.-M., Migliore-Samour, D., Drouet, L., and Caen, J.P., Peptides from milk proteins implicated in antithrombosis and immunomodulation, in New Perspectives in Infant Nutrition, Symposium Antwerp, Renner, B. and Sawatzki, G., Eds., Thieme Medical Publishers, New York, 1992, pp. 160-172.
61. Schlimme, E. and Meisel, H., Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects, Nahrung, 39, 1-20, 1995.
62. Migliore-Samour, D., Floch, F., and Jolles, P., Biologically active casein peptides implicated in immunomodulation, J. Dairy Res., 56, 357-362, 1989.
63. Meisel, H., Biochemical properties of regulatory peptides derived from milk proteins, Biopolymers, 43, 119-128, 1997.
64. Coste, M., Rochet, V., Leonil, J., Molle, D., Bouhallab, S., and Tome, D., Identification of C-terminal peptides of bovine beta-casein that enhance proliferation of rat lymphocytes, Immunol. Lett., 33, 41-46, 1992.
65. Miyauchi, H., Kaino, A., Shinoda, I., Fukuwatari, Y., and Hayasawa, H., Immunomodulatory effect of bovine lactoferrin pepsin hydrolysate on murine splenocytes and Peyer’s patch cells, J. Dairy Sci., 80, 2330-2339, 1997.
66. Miyauchi, H., Hashimoto, S., Nakajima, M., Shinoda, I., Fukuwatari, Y., and Hayasawa, H., Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain, Cell Immunol., 187, 34-37, 1998.
67. Pecquet, S., Bovetto, L., Maynard, F., and Fritsche, R., Peptides obtained by tryptic hydrolysis of bovine beta-lactoglobulin induce specific oral tolerance in mice, J. Allergy Clin. Immunol., 105, 514-521, 2000.
68. Bounous, G. and Kongshavn, P.A.L., Differential effect of dietary protein type on the B cell and T cell response in mice, J. Nutr., 115, 1403-1408, 1985.
69. Bounous, G. and Kongshavn, P.A.L., Influence of dietary proteins on the immune system of mice, J. Nutr., 112, 1747-1755, 1982.
70. Mattsby-Baltzer, I., Roseanu, A., Motas, C., Elverfors, J., Engberg, I., and Hanson, L.A., Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human manocytic cells, Pediatric Res., 40, 257-262, 1996.
71. Shinoda, I., Takase, M., Fukuwatari, Y., Shimamura, S., Koller, M., and Konig, W., Effects of lactoferrin and lactoferricin on the release of interleukin 8 from human polymorphonuclear leucocytes, Biosci. Biotech. Biochem., 60, 521-523, 1996.
72. Migliore-Samour, D. and Jolles, P., Casein, a prohormone with an immunomodulating role in the newborn? Experientia, 44, 188-193, 1988.
73. Elitsur, Y. and Luk, G.D., Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation, Clin. Exp. Immunol., 85, 493-497, 1991.
74. Maruyama, S., Mitachi, H., Awaya, J., Kurono, M., Tomizuka, N., and Suzuki, H., Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of alpha S1 casein, Agric. Biol. Chem., 51, 2557-2561, 1987.
75. Fiat, A.M., Migliore-Samour, D., Jolles, P., Drouet, L., Sollier, C.B., and Caen, J., Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities, J. Dairy Sci., 76, 301-310, 1993.
76. Matar, C., Goulet, J., Bernier, R.L., and Brochu, E., Bioactive peptides from fermented foods: their role in the immune system, in Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics, Fuller, R., Ed., Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000.
77. Matar, C., Valdez, J.C., Medina, M., Rachid, M., and Perdigon, G., Immunomodu-lating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant, J. Dairy Res., 68, 601-609, 2001.
78. LeBlanc, J.G., Matar, C., Valdez, J.C., LeBlanc, J., and Perdigon, G., Identification of a peptidic fraction in fermented milk that enhances the immune system response and regression of fibrosarcoma, J. Dairy Sci., (submitted).
79. Perdigon, G., Valdez, J.C., and Rachid, M., Antitumour activity of yogurt: study of possible immune mechanisms, J. Dairy Res., 65, 129-138, 1998.
80. Isolauri, E., Probiotics in human disease, Am. J. Clin. Nutr., 73, 1142S-1146S, 2001.
81. Maruyama, S., Mitachi, H., Awaya, J., Kurono, M., Tomizuka, N., and Suzuki, H., Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of alpha S1 casein, Agric. Biol. Chem., 51, 2557–2561, 1987.
82. Mullally, M.M., Meisel, H., and FitzGerald, R.J., Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity, Biol. Chem. Hoppe Seyler, 377, 259–260, 1996.
83. Mullaly, M., Meisel, H., and FitzGerald, R.J., Angiotensin-I-converting enzyme inhibitory activities of gastric and pancreatic proteinase digests of whey proteins, Int. Dairy J., 7, 299–303, 1997.
84. Rhyu, M., Nam, Y., and Lee, H., Screening of angiotensin-I-converting enzyme inhibitors in cereals and legumes, Food Biotechnol., 5, 334, 1996.
85. Ariyoshi, Y., Angiotensin-converting enzyme inhibitors derived from food proteins, Trends Food Sci. Technol., 4, 139–144, 1993.
86. Gobbetti, M., Smacchi, E., Corsetti, A., and Bellucci, M., Inhibition of proteolytic enzymes from Pseudomonas fluorescens ATCC 948 and angiotensin-I converting enzyme by peptides from zein, hordein and gluten hydrolysates, J. Food Prot., 60, 499–504, 1997.
87. Hata, Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y., and Takano, T., A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr., 64, 767–771, 1996.
88. Yamamoto, N., Akino, A., and Takano, T., Purification and specificity of a cell-wall-associated proteinase from Lactobacillus helveticus CP790, J. Biochem., 114, 740–745, 1993.
89. Sugai, R., ACE-inhibitors and functional foods, abstract, Int. Dairy Fed. Wk., Mar. 9–11, 1998.
90. Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S., and Takano, T., Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk, J. Dairy Sci., 78, 777–783, 1995.
91. Gobbetti, M., Ferranti, P., Smacchi, E., Goffredi, F., and Addeo, F., Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cre-moris FT4, Appl. Environ. Microbiol., 66, 3898–3904, 2000.
92. Yamamoto, N. and Takano, T., Antihypertensive peptides derived from milk proteins, Nahrung, 43, 159–164, 1999.
93. Yamamoto, N., Ono, H., Maeno, M., Ueda, Y., Takano, T., and Momose, H., Classification of Lactobacillus helveticus strains by immunological differences in extracellular proteinases, Biosci. Biotechnol. Biochem., 62, 1228–1230, 1998.
94. Yamamoto, N., Maeno, M., and Takano, T., Purification and characterization of an antihypertensive peptide from yogurt-like product fermented by Lactobacillus hel-veticus CPN4, J. Dairy Sci., 82, 1388–1393, 1999.
95. Urata, H., Boehm, K.D., Philip, A., Kinoshita, A., Gabrovsek, J., Bumpus, F.M., and Husain, A., Cellular localization and regional distribution of an angiotensin II–form-ing chymase in the heart, J. Clin. Invest., 91, 1269–1281, 1993.
96. Berthou, J., Migliore-Samour, D., Lifchitz, A., Delettre, J., Floc’h, F., and Jolles, P., Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins, FEBS Lett., 218, 55–58, 1987.
97. Ryhanen, E.-L., Pihlanto-Leppala, A., and Pahkala, E., A new type of ripened, low-fat cheese with bioactive properties, Int. Dairy J., 11, 441–447, 2001.
98. Hata, Y., Yamamoto, M., Ohni, M., Nakajima, K., Nakamura, Y., and Takano, T., A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects, Am. J. Clin. Nutr., 64, 767-771, 1996.
99. Takano T., Milk derived peptides and hypertension reduction, Int. Dairy J., 8, 375-381, 1998.
100. Kawakami, A. and Kayahara, H., Synthesis of Leu-Lys-Tyr derivatives and their interaction with angiotensin-I converting enzyme, J. Jpn. Soc. Nutr. Food Sci., 46, 425-428, 1993.
101. Maruyama, S. and Suzuki, H., A peptide inhibitor of angiotensin-I converting enzyme in the tryptic hydrolysate of casein, Agric. Biol. Chem., 46, 1393, 1982.
102. Maruyama, S., Nakagomi, K., Tomizuka, N., and Suzuki, H., Angiotensin I-convert-ing enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and ileum of rats, Agric. Biol. Chem., 49, 1405, 1985.
103. Pihlanto-Leppälä, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H., Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides, J. Dairy Res., 67, 53-64, 2000.
104. Matsui, T., Li, C.-H., and Osajima, Y., Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ, J. Peptide Sci., 5, 289-297, 1999.
105. Teschemacher, H., Koch, G., and Brandt, V., Milk protein derived opioid peptides and correlated compounds with antagonist activity, in ß-Casomorphins and Related Peptides: Recent Developments, Brandt, V. and Teschemacher, H., Eds., VCH-Wein-heim, Germany, 1994, pp. 9-14.
106. Meisel, H. and FitzGerald, R.J., Opioid peptides encrypted in intact milk protein sequences, Br. J. Nutr., 84, S27-S31, 2000.
107. Antila, P., Paakkari, I., Jarvinen, A., Mattila, M.J., Laukkanen, M., Pihlanto-Leppälä, A., Mantsala, P., and Hellman, J., Opioid peptides derived from in vitro proteolysis of bovine whey proteins, Int. Dairy J., 1, 215-229, 1991.
108. Teschemacher, H., Koch, G., and Brantl, V., Milk protein-derived opioid receptor ligands, Biopolymers, 43, 99-117, 1997.
109. Brantl, V., Teschemacher, H., Henschen, A., and Lottspeich, F., Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone, Hoppe Seyler’s Physiol. Chem., 360, 1211-1216, 1979.
110. Henschen, A., Lottspeich, F., Brandt, V., and Teschemacher, H., Novel opioid peptides derived from casein, ß-casomorphins. II. Structure of active components from bovine casein peptone, Hoppe Seyler’s Physiol. Chem., 360, 1217-1224, 1979.
111. Yoshikawa, M., Tani, F., Ashikaga, T., Yoshimura, T., and Chiba, H., Opioid peptides from milk proteins, Agric. Biol. Chem., 50, 2419-2421, 1986.
112. Chang, K.J., Killian, A., Hazum, E., and Cuatrecasas, P., Morphiceptin (NH4-Tyr-Pro-Phe-Pro-CONH2): a potent and specific agonist for the morphine (µ) receptors, Science, 212, 75-77, 1981.
113. Mierke, D.F., Nobner, G., Shiller, P.W., and Goodman, M., Morphiceptin analogs containing 2-aminocyclopentane carboxylic acid as a peptidomimetic for proline, Int. J. Peptide Res., 35, 34-45, 1990.
114. Matthies, H., Stark, H., Hartrodt, B., Ruethrich, H.L., Spieler, H.T., Barth, A., and Neubert, K., Derivatives of beta-casomorphins with high analgesic potency, Peptides, 5, 463-470, 1984.
115. Paroli, E., Opioid peptides from food (the exorphins), World Rev. Nutr. Diet., 55, 58-97, 1988.
116. Meisel, H. and Schlimme, E., Milk proteins: precursors of bioactive peptides, Trends Food Sci. Technol., 1, 41–43, 1990.
117. Hautefeuille, M., Brandt, V., Dumontier, A.-M., and Desjeux, J.-F., In vitro effects of ß-casomorphins on ion transport in rabbit ileum, Am. J. Physiol., 250, G92–G97, 1986.
118. Tomé, D., Dumontier, A.M., Hautefeuille, M., and Desjeux, J.F. Opiate activity and transepithelial passage of intact ß-casomorphins in rabbit ileum, Am. J. Physiol., 253, G737–G744, 1987.
119. Mansour, B.A., Tomé, D., Rautureau, M., Bisalli, A., and Desjeux, J.-F., Luminal anti-secretory effects of a casomorphin analogue on rabbit ileum treated with cholera toxin, Pediatr. Res., 24, 751–755, 1988.
120. Mahé, S., Tomé, D., Dumontier, A.M., and Desjeux, J.-F., Absorption of intact ß-casomorphins (ß-CM) in rabbit ileum in vitro, Reprod. Nutr. Dévelop., 29, 725–732, 1989.
121. Daniel, H., Vohwinkel, M., and Rehner, G., Effect of casein and beta-casomorphins on gastrointestinal motility in rats, J. Nutr., 120, 252–257, 1990.
122. Defilippi, C. and Gomez, E., Effect of casein and casein hydrolysate on small bowel motility and D-xylose absorption in dogs, Neurogastroenterol. Motil., 7, 229–234, 1995.
123. Schanbacher, F.L., Talhouk, R.S., Murray, F.A., Gherman, L.I., and Willett, L.B., Milk-borne bioactive peptides, Int. Dairy J., 8, 393–403, 1998.
124. Ermisch, A., Brust, P., and Brandsch, M., ß-Casomorphins alter the intestinal accumulation of L-leucine, Biochim. Biophys. Acta, 982, 79–84, 1989.
125. Erll, G., Hahn, A., Brandt, V., and Daniel, H., ß-Casomorphins and intestinal net fluid transport in vivo, in ß-Casomorphins and Related Peptides: Recent Developments, Brandt, V. and Teschemacher, H., Eds., VCH, Weinheim, 1994, pp. 143–149.
126. Hamel, U., Kielwein, G., and Teschemacher, H., Beta-casomorphin immunoreactive materials in cow’s milk incubated with various bacterial species, J. Dairy Res., 52, 139–148, 1985.
127. Muehlenkamp, M.R. and Warthesen, J.J., ß-Casomorphins: analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris, J. Dairy Sci., 79, 20–26, 1996.
128. Nuijens, J.H., van Berkel, P.H.C., and Schanbacher, F.L., Structure and biological actions of lactoferrin, J. Mammary Gland Biol. Neoplasia, 1, 285–294, 1996.
129. Schanbacher, F.L., Talhouk, R.S., and Murray, F.A., Biology and origin of bioactive peptides in milk, Livestock Product. Sci., 50, 105-123, 1997.
130. Loukas, S., Varoucha, D., Zioudrou, C., Straty, R.A., and Klee, W.A., Opioid activities and structures of alpha casein-derived exorphins, Biochemistry, 22, 4567-4573, 1983.
131. Chiba, H., Tani, F., and Yoshikawa, M., Opioid antagonist peptides derived from ĸ-casein, J. Dairy Res., 56, 363-366, 1989.
132. Fiat, A.M. and Jolles, P., Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects, Mol. Cell Bio-chem., 87, 5-30, 1989.